Cheeky Bonsai Uti Pain Relief Tablet
Product Images NDC 81860-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cheeky Bonsai Uti Pain Relief (NDC 81860-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ixxa, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of Carton (Carton)

Image Of Carton (Carton)
This is a drug facts and cautionary label for tablets containing Phenazopyridine Hydrochloride for fast relief of urinary pain, burning, urgency, and frequency associated with urinary tract infections, for a maximum of 2 days. It warns not to exceed recommended dosage and that the product may cause reddish-orange urine and stomach upset. It advises seeking medical attention if the symptoms persist beyond 2 days and adverse reaction to the medication is suspected. It recommends consulting a doctor before using the tablets for kidney disease, allergies to food or dyes, had hypersensitive reactions to phenazopyridine, pregnant or breastfeeding. If overdosed, medical help or contacting a Poison Control Center is recommended. The direction for adults and children 12 years and over is to take two tablets three times a day with a full glass of water, with or after meals as needed. Children under 12 years should consult a doctor before use. It warns the product may intervene with laboratory tests and can stain contact lenses. The tablets are distributed by Cheeky Bonsai DS Nakheeselod in San Francisco, CA, and made in the USA. Contact information is provided for questions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.